SANTA CLARA, Calif.--(BUSINESS WIRE)--Mar. 18, 2015--
Agilent Technologies Inc. (NYSE: A) today announced that Daniel K.
Podolsky, M.D., president of the University of Texas Southwestern
Medical Center, has been appointed to the company’s board of directors,
effective in July. Dr. Podolsky’s appointment increases Agilent’s board
to 10 members.
“We are very pleased to welcome Dr. Podolsky to the Agilent board of
directors,” said James G. Cullen, Agilent chairman. “He is an excellent
addition at an important time in the company’s growth. Dr. Podolsky has
a depth of knowledge from his many years as a leader in the medical
field, as well as a practical business sense as president of a top
medical center. His insights into health care delivery issues are
particularly relevant as Agilent continues its growth in the life
science solutions and diagnostics markets.”
UT Southwestern Medical Center in Dallas is a leading academic medical
center, patient care provider and research institution. Dr. Podolsky has
served as its president since 2008.
He was previously chief academic officer and faculty dean, Academic
Programs, for Partners Health System, Inc., a Boston-based nonprofit
health care system committed to patient care, research, teaching and
service. He also served concurrently as the Mallinckrodt Professor of
Medicine at Harvard Medical School and the Chief of Gastroenterology at
Massachusetts General Hospital.
“I am honored to be joining the Agilent board of directors,” Dr.
Podolsky said. “The company has long been known for the quality of its
products and people, and is now at a pivotal point in leveraging its
experience into new and growing medical-related markets. I look forward
to supporting its growth and success.”
Dr. Podolsky holds the Philip O’Bryan Montgomery, Jr., M.D.,
Distinguished Presidential Chair in Academic Administration, and the
Doris and Bryan Wildenthal Distinguished Chair in Medical Science at the
University of Texas Southwestern Medical Center. He is a member of the
Institute of Medicine of the U.S. National Academy of Sciences; the
board of the Southwestern Medical Foundation; and the Scientific
Advisory Board of Antibe Therapeutics, Inc., a company focused on the
treatment of diseases characterized by inflammation, pain and/or
vascular dysfunction. Dr. Podolsky is also a member of the National
Academies of Sciences Board on Army Science and Technology, and he
serves on the board of directors of the pharmaceutical company
GlaxoSmithKline.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences,
diagnostics and applied chemical markets, is the premier laboratory
partner for a better world. Agilent works with customers in more than
100 countries, providing instruments, software, services and consumables
for the entire laboratory workflow. Agilent generated revenues of $4.0
billion in fiscal 2014. The company employs about 12,000 people
worldwide. Information about Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and executive
news is available at www.agilent.com/go/news.
Source: Agilent Technologies Inc.
EDITORIAL CONTACT:
Agilent Technologies Inc.
Michele Drake,
+1-408-345-8396
michele_drake@agilent.com
INVESTOR
CONTACT:
Alicia Rodriguez,+1-408-345-8948
alicia_rodriguez@agilent.com